I agree that this site is using cookies. You can find further informations here.
X
Fury, Matthew G.
155  results:
Search for persons X
?
1

Health-Related Quality of Life in Patients with Metastatic ..:

Lewis, Karl D ; Inocencio, Timothy J ; Quek, Ruben GW...
SKIN The Journal of Cutaneous Medicine.  8 (2024)  1 - p. s337 , 2024
Link: https://doi.org/10.25251..
 
?
2

High response rate with extended dosing of cemiplimab in ad..:

Rischin, Danny ; Hughes, Brett G M ; Basset-Séguin, Nicole...
Journal for ImmunoTherapy of Cancer.  12 (2024)  3 - p. e008325 , 2024
Link: https://doi.org/10.1136/..
 
?
3

Neoadjuvant cemiplimab and surgery for stage II–IV cutaneou..:

Gross, Neil D ; Miller, David M ; Khushalani, Nikhil I...
The Lancet Oncology.  24 (2023)  11 - p. 1196-1205 , 2023
Link: https://doi.org/10.1016/..
 
?
4

Primary analysis of Phase 2 results for cemiplimab in patie..:

Lewis, Karl D ; Peris, Ketty ; Sekulic, Aleksandar...
SKIN The Journal of Cutaneous Medicine.  7 (2023)  2 - p. s177 , 2023
Link: https://doi.org/10.25251..
 
?
5

Phase 2 study of cemiplimab in patients with locally advanc..:

Stratigos, Alexander J ; Sekulic, Aleksandar ; Peris, Ketty...
SKIN The Journal of Cutaneous Medicine.  7 (2023)  2 - p. s178 , 2023
Link: https://doi.org/10.25251..
 
?
6

Pharmacodynamic and therapeutic pilot studies of single-age..:

Burman, Bharat ; Drutman, Scott B. ; Fury, Matthew G....
Oral Oncology.  128 (2022)  - p. 105806 , 2022
Link: https://doi.org/10.1016/..
 
?
7

Hedgehog pathway inhibitor real-world treatment patterns in..:

Ge, Wenzhen ; Chen, Chieh-I ; Wu, Ning...
Future Oncology.  18 (2022)  23 - p. 2561-2572 , 2022
Link: https://doi.org/10.2217/..
 
?
8

EMPOWER CERVICAL-1: Effects of cemiplimab versus chemothera..:

Oaknin, Ana ; Monk, Bradley J. ; Vergote, Ignace...
European Journal of Cancer.  174 (2022)  - p. 299-309 , 2022
Link: https://doi.org/10.1016/..
 
?
9

Real-World Treatment Patterns and Outcomes Among Patients w..:

Cowey, Lance ; Chen, Chieh-I. ; Aguilar, Kathleen M....
Dermatology and Therapy.  12 (2022)  5 - p. 1211-1224 , 2022
Link: https://doi.org/10.1007/..
 
?
10

Tolerability and antitumor activity of cemiplimab, a human ..:

Moreno, Victor ; Garrido, Pilar ; Papadopoulos, Kyriakos P....
Lung Cancer.  155 (2021)  - p. 151-155 , 2021
Link: https://doi.org/10.1016/..
 
?
11

Fixed Dose of Cemiplimab in Patients with Advanced Malignan..:

Paccaly, Anne J. ; Migden, Michael R. ; Papadopoulos, Kyriakos P....
Advances in Therapy.  38 (2021)  5 - p. 2365-2378 , 2021
Link: https://doi.org/10.1007/..
 
?
12

Integrated analysis of a phase 2 study of cemiplimab in adv..:

Rischin, Danny ; Khushalani, Nikhil I ; Schmults, Chrysalyne D...
Journal for ImmunoTherapy of Cancer.  9 (2021)  8 - p. e002757 , 2021
Link: https://doi.org/10.1136/..
 
?
13

A Phase 1b Study of Cetuximab and BYL719 (Alpelisib) Concur..:

Dunn, Lara A. ; Riaz, Nadeem ; Fury, Matthew G....
International Journal of Radiation Oncology*Biology*Physics.  106 (2020)  3 - p. 564-570 , 2020
Link: https://doi.org/10.1016/..
 
?
14

PD-1 blockade in recurrent or metastatic cervical cancer: D..:

Rischin, Danny ; Gil-Martin, Marta ; González-Martin, Antonio...
Gynecologic Oncology.  159 (2020)  2 - p. 322-328 , 2020
Link: https://doi.org/10.1016/..
 
?
15

Phase 2 study of cemiplimab in patients with metastatic cut..:

Rischin, Danny ; Migden, Michael R ; Lim, Annette M...
Journal for ImmunoTherapy of Cancer.  8 (2020)  1 - p. e000775 , 2020
Link: https://doi.org/10.1136/..
 
1-15